Yong-Jun Li Selected Research

Yong-Jun Li Research Topics

Disease

6	Myocardial Infarction 01/2021 - 02/2009
5	Thrombosis (Thrombus) 11/2019 - 10/2011
5	Ischemia 01/2018 - 02/2007
4	Myocardial Ischemia (Ischemic Heart Diseases) 08/2022 - 01/2018
4	Neoplasms (Cancer) 10/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 10/2017
3	Atherosclerosis 04/2022 - 10/2017
3	Rheumatoid Arthritis 03/2022 - 08/2018
3	Necrosis 01/2021 - 09/2003
3	Acute Coronary Syndrome 04/2018 - 05/2013
2	Infarction (Infarctions) 01/2021 - 08/2020
2	ST Elevation Myocardial Infarction 08/2020 - 01/2019
2	Pathologic Constriction (Stenosis) 01/2019 - 02/2009
2	Inflammation (Inflammations) 10/2017 - 05/2013
2	Edema (Dropsy) 07/2017 - 04/2011
2	Chronic Hepatitis (Chronic Active Hepatitis) 01/2017 - 05/2014
2	Urinary Tract Infections (Urinary Tract Infection) 12/2014 - 04/2011
2	Diabetes Mellitus 09/2009 - 06/2007
2	Hypertrophy 09/2004 - 08/2004
2	Tuberculosis (Tuberculoses) 09/2003 - 11/2002
1	Colorectal Neoplasms (Colorectal Cancer) 06/2022
1	Silicosis 06/2022
1	Marfan Syndrome (Marfan's Syndrome) 03/2022
1	Aortic Dissection 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2021
1	Reperfusion Injury 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 08/2019
1	T-Cell Leukemia (Leukemia, T Cell) 08/2019
1	Arthritis (Polyarthritis) 08/2018
1	Rheumatic Diseases (Rheumatism) 08/2018
1	Arthralgia (Joint Pain) 08/2018
1	Vascular System Injuries 07/2018

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2021 - 11/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
3	Biological ProductsIBA 06/2022 - 01/2019
3	tetrandrineIBA 06/2022 - 10/2017
3	AlkaloidsIBA 06/2022 - 10/2017
3	TabletsIBA 01/2017 - 05/2010
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2022
2	Caspase 3 (Caspase-3)IBA 11/2021 - 09/2003
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 09/2003
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2019 - 09/2004
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2019 - 10/2017
2	Long Noncoding RNAIBA 01/2019 - 10/2017
2	caffeoylquinic acidIBA 08/2018 - 01/2012
2	LipidsIBA 07/2018 - 08/2006
2	tetramethylpyrazineIBA 05/2018 - 04/2018
2	Xylenes (Xylene)IBA 07/2017 - 04/2011
2	ResveratrolIBA 06/2017 - 10/2008
2	Oleanolic AcidIBA 01/2017 - 05/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 09/2009
2	Therapeutic UsesIBA 12/2014 - 05/2013
2	CytokinesIBA 05/2013 - 09/2004
2	DNA (Deoxyribonucleic Acid)IBA 09/2004 - 08/2004
2	Leucine (L-Leucine)FDA Link 09/2004 - 08/2004
1	AntioxidantsIBA 08/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2022
1	Antineoplastic Agents (Antineoplastics)IBA 06/2022
1	AcidsIBA 06/2022
1	Capsules (Microcapsules)IBA 03/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2021
1	ProteomeIBA 11/2021
1	pyrimidineIBA 10/2021
1	kaempferol-7-methyl etherIBA 10/2021
1	Ether (Diethyl Ether)IBA 10/2021
1	galanginIBA 10/2021
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	CalpainIBA 01/2021
1	Carbolines (Beta-Carbolines)IBA 01/2021
1	ATP Translocases Mitochondrial ADPIBA 01/2021
1	TicagrelorIBA 01/2021
1	Clopidogrel (Plavix)FDA Link 01/2021
1	calpain 10IBA 01/2021
1	CPI 1189IBA 01/2021
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2021
1	polydatinIBA 01/2021
1	GoldIBA 09/2020
1	polydopamineIBA 09/2020
1	Nicorandil (SG 75)IBA 08/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	SolutionsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 08/2019
1	Phenobarbital (Luminal)FDA Link 01/2019
1	anisodamineIBA 01/2019
1	N(2)-(3-trifluoromethylphenyl)guanineIBA 01/2019
1	saruplaseIBA 01/2019
1	CardenolidesIBA 08/2018

Therapy/Procedure

7	Therapeutics 03/2022 - 02/2007
4	Percutaneous Coronary Intervention 08/2020 - 01/2014
3	Endovascular Aneurysm Repair 01/2022 - 10/2011
3	Stents 11/2019 - 10/2011
2	Catheters 01/2019 - 01/2012
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2018 - 04/2018
1	Photothermal Therapy 09/2020
1	Drug Therapy (Chemotherapy) 08/2019
1	Perioperative Period 01/2019